Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/141958
Title: Non-viral gene therapy using multifunctional nanoparticles : status, challenges, and opportunities
Authors: Lin, Guimiao
Li, Li
Panwar, Nishtha
Wang, Jie
Tjin, Swee Chuan
Wang, Xiaomei
Yong, Ken-Tye
Keywords: Engineering::Electrical and electronic engineering
Issue Date: 2018
Source: Lin, G., Li, L., Panwar, N., Wang, J., Tjin, S. C., Wang, X., & Yong, K.-T. (2018). Non-viral gene therapy using multifunctional nanoparticles : status, challenges, and opportunities. Coordination Chemistry Reviews, 374, 133-152. doi:10.1016/j.ccr.2018.07.001
Journal: Coordination Chemistry Reviews
Abstract: Gene delivery for molecular-level therapeutics is regarded as a prospective remedial route to cure human diseases by the medical community. The major challenge for delivering genes in vivo is the lack of suitable delivery vehicles possessing high transfection efficiencies and low cytotoxicity. Currently, viral vectors such as retroviruses, lentiviruses, adenoviruses, adeno-associated viruses (AAV), and herpes simplex viruses (HSV) are being used as successful vectors at clinical trial levels. However, their use has raised major concerns related to insertion mutagenesis and immunogenicity in the medical research community. To address these issues, several non-viral gene delivery vectors are being explored. Among these non-viral vectors, multifunctional nanoparticles have shown superior performance in terms of enhanced gene stability, shielding of cargo from nuclease degradation, and improved passive/active targeting. This review focuses on the explicit role of various non-viral, multifunctional nanoparticles such as lipid-based nanoparticles, quantum dots (QDs), carbon nanotubes, magnetic nanoparticles, silica nanoparticles, and polymer-based nanoparticles, in distinct gene delivery strategies namely, image-guided gene delivery, optically-trackable and optically-activated gene therapy, combinational gene therapy, and present their proficiency in crossing the biological barriers. Furthermore, we highlight the applications of multifunctional nanoparticles as efficient nanovehicles in gene therapy of infectious diseases, cancers, and brain dysfunctional diseases. More importantly, we discuss the in vitro and in vivo toxicity assessments of these multifunctional nanoparticles. Summarily, we outline the present challenges that need urgent attention to translate the progress in between in vitro nanomedicine to clinical research, which may eventually lead us to advance clinical therapeutics for chronic diseases.
URI: https://hdl.handle.net/10356/141958
ISSN: 0010-8545
DOI: 10.1016/j.ccr.2018.07.001
Rights: © 2018 Elsevier B.V. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:EEE Journal Articles

SCOPUSTM   
Citations 10

33
Updated on Mar 10, 2021

PublonsTM
Citations 10

29
Updated on Mar 7, 2021

Page view(s)

32
Updated on Jun 15, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.